N-[1-[2-[2-(3,4-dichlorophenyl)-4-(4-fluorophenyl)-5-oxomorpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]acetamide

C31H32Cl2FN3O3 — CID 67012453

IUPACN-[1-[2-[2-(3,4-dichlorophenyl)-4-(4-fluorophenyl)-5-oxomorpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]acetamide
SMILESCC(=O)NC1(c2ccccc2)CCN(CCC2(c3ccc(Cl)c(Cl)c3)CN(c3ccc(F)cc3)C(=O)CO2)CC1
InChIInChI=1S/C31H32Cl2FN3O3/c1-22(38)35-30(23-5-3-2-4-6-23)13-16-36(17-14-30)18-15-31(24-7-12-27(32)28(33)19-24)21-37(29(39)20-40-31)26-10-8-25(34)9-11-26/h2-12,19H,13-18,20-21H2,1H3,(H,35,38)
InChIKeyVSEJZVYQMIRUBL-UHFFFAOYSA-N
MW584.52 g/mol
LogP5.91
Rot. Bonds7

About N-[1-[2-[2-(3,4-dichlorophenyl)-4-(4-fluorophenyl)-5-oxomorpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]acetamide

N-[1-[2-[2-(3,4-dichlorophenyl)-4-(4-fluorophenyl)-5-oxomorpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]acetamide (PubChem CID 67012453) has the molecular formula C31H32Cl2FN3O3 and a molecular weight of 584.52 g/mol. Its IUPAC name is N-[1-[2-[2-(3,4-dichlorophenyl)-4-(4-fluorophenyl)-5-oxomorpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]acetamide.

Molecular Properties

Compound NameN-[1-[2-[2-(3,4-dichlorophenyl)-4-(4-fluorophenyl)-5-oxomorpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]acetamide
PubChem CID67012453
Molecular FormulaC31H32Cl2FN3O3
Molecular Weight584.52 g/mol
Exact Mass583.18
IUPAC NameN-[1-[2-[2-(3,4-dichlorophenyl)-4-(4-fluorophenyl)-5-oxomorpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]acetamide
SMILESCC(=O)NC1(c2ccccc2)CCN(CCC2(c3ccc(Cl)c(Cl)c3)CN(c3ccc(F)cc3)C(=O)CO2)CC1
InChIInChI=1S/C31H32Cl2FN3O3/c1-22(38)35-30(23-5-3-2-4-6-23)13-16-36(17-14-30)18-15-31(24-7-12-27(32)28(33)19-24)21-37(29(39)20-40-31)26-10-8-25(34)9-11-26/h2-12,19H,13-18,20-21H2,1H3,(H,35,38)
InChIKeyVSEJZVYQMIRUBL-UHFFFAOYSA-N
XLogP5.91
TPSA61.88 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds7
Heavy Atoms40
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500584.52
LogP ≤ 55.91
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze N-[1-[2-[2-(3,4-dichlorophenyl)-4-(4-fluorophenyl)-5-oxomorpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[1-[2-[2-(3,4-dichlorophenyl)-4-(4-fluorophenyl)-5-oxomorpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]acetamide?
The IUPAC name of N-[1-[2-[2-(3,4-dichlorophenyl)-4-(4-fluorophenyl)-5-oxomorpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]acetamide (CID 67012453) is N-[1-[2-[2-(3,4-dichlorophenyl)-4-(4-fluorophenyl)-5-oxomorpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]acetamide.
What is the SMILES notation for N-[1-[2-[2-(3,4-dichlorophenyl)-4-(4-fluorophenyl)-5-oxomorpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]acetamide?
The canonical SMILES for N-[1-[2-[2-(3,4-dichlorophenyl)-4-(4-fluorophenyl)-5-oxomorpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]acetamide is CC(=O)NC1(c2ccccc2)CCN(CCC2(c3ccc(Cl)c(Cl)c3)CN(c3ccc(F)cc3)C(=O)CO2)CC1.
What is the InChIKey of N-[1-[2-[2-(3,4-dichlorophenyl)-4-(4-fluorophenyl)-5-oxomorpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]acetamide?
The InChIKey is VSEJZVYQMIRUBL-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H32Cl2FN3O3/c1-22(38)35-30(23-5-3-2-4-6-23)13-16-36(17-14-30)18-15-31(24-7-12-27(32)28(33)19-24)21-37(29(39)20-40-31)26-10-8-25(34)9-11-26/h2-12,19H,13-18,20-21H2,1H3,(H,35,38).
What are the key properties of N-[1-[2-[2-(3,4-dichlorophenyl)-4-(4-fluorophenyl)-5-oxomorpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]acetamide?
N-[1-[2-[2-(3,4-dichlorophenyl)-4-(4-fluorophenyl)-5-oxomorpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]acetamide has a molecular weight of 584.52 g/mol, XLogP of 5.91, 7 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[2-[2-(3,4-dichlorophenyl)-4-(4-fluorophenyl)-5-oxomorpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]acetamide is sourced from PubChem (CID 67012453), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).